Burkholderia species, notably Burkholderia cepacia and Burkholderia gladioli, are important pathogens in patients with chronic granulomatous disease (CGD). Burkholderia pseudomallei, the causative agent of melioidosis, is endemic in Southeast Asia and northern Australia but is a rare pathogen in other parts of the world. We describe the occurrence of B. pseudomallei infection in a Puerto Rican patient with CGD. This is one of only a small number of documented cases of melioidosis autochthonous to the Americas and is the first reported case of B. pseudomallei infection in a CGD patient from the Americas. We conclude that B. pseudomallei, like B. cepacia and B. gladioli, should be considered a potential pathogen in patients with CGD and that melioidosis should be considered in the differential diagnosis for ill residents of or travelers to Puerto Rico.
Chronic granulomatous disease (CGD) is caused by one of was in Puerto Rico and had not decreased with oral amoxicillin/ clavulanate therapy. He had a long history of recurrent bacterial several genetic lesions involving the phagocyte NADPH oxidase system; it is characterized by defective production of toxic and aspergillus pneumonias, pyogenic liver abscesses, osteomyelitis, sinusitis, and granulomatous gastritis. Two years beoxygen metabolites by neutrophils and ineffective microbial killing. Patients with CGD characteristically have recurrent fore the current hospitalization, he had undergone right upper lobectomy for treatment of refractory pneumonia due to Nocarpyogenic infections, especially those due to organisms possessing catalase activity. Burkholderia species are important dia otitidiscaviarum. Six months before admission, he had Phialophora melinii soft-tissue infection of the foot that was pathogens in patients with CGD. In such patients, Burkholderia cepacia can cause pneumonia, bacteremia, skin abscesses, certreated initially with amphotericin B and then with itraconazole, which he was taking at the time of admission. Other medicavical adenitis, and widely disseminated fatal infection [1 -4] . The first reported cases of human disease caused by Burkholdtions included trimethoprim-sulfamethoxazole and IFN-g prophylaxis. He had been born to Puerto Rican parents in Naguabo, eria gladioli were in two North American patients with CGD. Both patients had B. gladioli pneumonia, which in one case Puerto Rico, and continued to reside there on a farm. His only travel was to New York City and the Washington, D.C., area was associated with B. gladioli bacteremia and sepsis syndrome [5] . A subsequent case of B. gladioli bacteremia in a European for medical care; no family members or close contacts had recently traveled. patient with CGD has been reported [6] .
Physical examination at the time of admission revealed a We report the occurrence of Burkholderia pseudomallei temperature of 38.5ЊC and a tender right supraclavicular mass. lymphadenitis and mediastinitis in a Puerto Rican patient with A chest CT revealed a right hilar mass, right hilar lymphade-CGD. This is the first reported case of B. pseudomallei infection nopathy, right paraesophageal lymphadenopathy, and a in a CGD patient from the Americas and is one of a small 2.5-cm right supraclavicular mass ( Figure 1A) . A direct biopsy number of cases of melioidosis autochthonous to the Americas. specimen of the right supraclavicular mass and a transthoracic needle biopsy specimen of the hilar mass were obtained. RouCase Report tine blood cultures were negative. Empirical therapy with ceftriaxone, trimethoprim-sulfamethoxazole, and amphotericin B An 11-year-old Puerto Rican boy with X-linked CGD was and daily granulocyte transfusions were started. IFN-g therapy hospitalized because of 2 weeks' duration of productive cough, was continued. right neck pain, and fever that had begun in October while he Direct smears were prepared from the right supraclavicular and hilar biopsy specimens. The biopsy specimens were submitted for routine, fungal, and mycobacterial cultures. Smears the right supraclavicular and hilar biopsy specimens on the positive for both IgG (titer, 3.1; reference titer range, õ2.0) and IgM (titer, 15.7; reference titer range, õ2.0). chocolate agar plates incubated at 35ЊC in 6% CO 2 yielded scant growth of a gram-negative rod.
Antibiotic susceptibility testing by means of the Autoscan system (Dade International) showed that the organism was re-A commercially available bacterial identification test (API NFT, bioMérieux Vitek, Hazelwood, MO) was used, as were sistant to ampicillin, amikacin, aztreonam, cefazolin, cefoxitin, ciprofloxacin, gentamicin, ticarcillin, tobramycin, and trimethconventional biochemical reactions for definitive identification. Identification and susceptibility tests were performed with use oprim-sulfamethoxazole and susceptible to ampicillin/sulbactam, ceftazidime, ceftriaxone, imipenem, piperacillin, and tetraof the MicroScan Negative Breakpoint Combo (Type 8) panels (Dade International, Deerfield, IL). After 24 hours, results of cycline. Susceptibility to chloramphenicol and doxycycline was determined by the Etest (AB BIODISK, Solna, Sweden). the MicroScan system were nondefinitive, thus suggesting that the organism was a ''rare biotype.'' Upon repeated testing, the On the basis of culture results and antibiotic susceptibility testing, therapy was changed to imipenem and doxycycline. MicroScan system made the identification of Chromobacterium violaceum (99.6% probability), while the API NFT system sugAmphotericin B and trimethoprim-sulfamethoxazole therapy was stopped. After 1 week of the new therapy, the patient gested B. pseudomallei as the presumptive identification.
The organism grew on blood and chocolate agars as creamy, became afebrile. Granulocyte transfusions were discontinued after 2 weeks. A chest CT after 3 weeks of therapy showed white, entire, low convex colonies; after 4 days of incubation, colonies became dry and wrinkled. The organism was catalasesignificant decreases in the sizes of the right supraclavicular and hilar masses ( Figure 1B ). He received 6 weeks of intravenous positive, weakly oxidase-positive, and nonfermentative. By conventional biochemical testing, it was capable of oxidizing imipenem and doxycycline therapy, followed by oral cefixime and doxycycline treatment. Three weeks after his discharge glucose, mannitol, sucrose, lactose, and maltose. Triple sugar iron testing showed an acid slant with no change in the butt from the hospital, while oral antibiotic therapy was still being prescribed, the patient developed fever and cough in Puerto portion. The organism was motile and showed negative reactions when tested for growth on citrate; esculin and acetamide Rico. He died en route to a hospital; permission for an autopsy could not be obtained. hydrolysis; production of indole, lysine, and ornithine decarboxylases; urease; acid from xylose; and utilization of o-nitrophenyl-B-D-galactopyranoside. The organism was positive Discussion for nitrate reduction to nitrite as well as for production of N 2 gas, arginine dihydrolase, gelatinase, and DNase. The organism
The genus Burkholderia includes five species known to cause human infection -B. cepacia, B. gladioli, Burkholderia pickhad multiple (three to five) polar flagella and produced white pigment. ettii (a rare cause of nosocomial urinary tract infection and bacteremia [7] ), B. pseudomallei (the agent of melioidosis), These features were consistent with the identification of B. pseudomallei, and this identification was subsequently conand Burkholderia mallei (the agent of glanders, a disease of livestock and rarely humans [8] [20] . The seroconversion rate among Thai children is 24% per domallei, and it has been shown to be very accurate (ú99%) in identifying known strains of this organism [9] . The antibiotic year, and the rate of seropositivity plateaus at 80% after 4 years of age [21] . susceptibility pattern of the patient's isolate was typical for B. pseudomallei, showing susceptibility to piperacillin, ampiSporadic reported cases of human melioidosis have occurred in China, Hong Kong, Korea, the Philippines, Indonesia, Guam, cillin/sulbactam, ceftazidime, imipenem, and tetracycline and resistance to aminoglycosides. Resistance to trimethoprim-sulNew Guinea, Western Australia, Fiji, India, Sri Lanka, Bangladesh, Pakistan, Kenya, West Africa, Iran, and Turkey (reviewed famethoxazole is increasing, especially in Thailand, where õ20% of strains are susceptible [10] .
in [22] In three cases reported as human melioidosis acquired in the of relapse after apparent clinical resolution of primary infection has been reported to be 15% per year of follow-up [13] .
United States, the bacterial isolates were atypical for B. pseudomallei, and identification as B. pseudomallei was not Antibiotic therapy for B. pseudomallei infection should be based on the severity of clinical disease, host factors, and results confirmed by a reference laboratory. These isolates include the organism described by Garry and Koch [32] , which produced of antimicrobial susceptibility testing. For severe disease, including septicemia, combination therapy is recommended. Ceftazia soluble bluish green pigment, as well as the organisms described by Beamer and colleagues [33, 34] , and McDowell and dime plus trimethoprim-sulfamethoxazole has recently been advocated on the basis of good in vitro activity of these agents Varney [35] . The antibiograms of 24 clinical isolates reported to be B. pseudomallei indigenous to Chile [38] and of 18 cliniand favorable clinical response in small numbers of treated patients [14, 15] . However, in vitro, the carbapenems imipenem cal isolates reported to be B. pseudomallei indigenous to El Salvador [39] were inconsistent with this species; the identities and meropenem have been shown to have more rapid bactericidal activity against B. pseudomallei than ceftazidime [16] and of those clinical isolates remain in doubt [22] . The source of disseminated melioidosis in a neonate born in the United States longer postantibiotic effects than other b-lactam agents [17] . For severe disease, several weeks of combination intravenous was not determined, but sexual transmission from father (a healthy Vietnam War veteran) to mother, followed by infection therapy followed by prolonged oral therapy is recommended. Our patient responded well to 6 weeks of intravenous imipenem of the fetus in utero or during parturition, cannot be excluded [40] . and doxycycline therapy and initially did well after transition to oral cefixime and doxycycline therapy. The cause of his death A single case of melioidosis has previously been described in a 3-year-old boy with CGD [41] . He was born in Singapore 4 weeks after changing to oral therapy could not be ascertained, and clinical response therefore cannot be fully evaluated; howto parents of European descent and was living in Singapore at the time of diagnosis of B. pseudomallei osteomyelitis. He was ever, relapse of melioidosis cannot be excluded.
B. pseudomallei is endemic in parts of Southeast Asia and initially treated with tetracycline without clinical improvement. A 5-week course of chloramphenicol and kanamycin therapy northern Australia where it can be found in soil and surface / 9c4a$$ap15 03-07-98 01:09:39 cida UC: CID 
